Intervention Review

You have free access to this content

Pharmacotherapy for trichotillomania

  1. Rachel Rothbart1,
  2. Taryn Amos2,
  3. Nandi Siegfried2,
  4. Jonathan C Ipser2,
  5. Naomi Fineberg3,
  6. Samuel R Chamberlain4,
  7. Dan J Stein2,*

Editorial Group: Cochrane Common Mental Disorders Group

Published Online: 8 NOV 2013

Assessed as up-to-date: 31 JUL 2013

DOI: 10.1002/14651858.CD007662.pub2

How to Cite

Rothbart R, Amos T, Siegfried N, Ipser JC, Fineberg N, Chamberlain SR, Stein DJ. Pharmacotherapy for trichotillomania. Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD007662. DOI: 10.1002/14651858.CD007662.pub2.

Author Information

  1. 1

    University of British Columbia, Department of Psychiatry, Vancouver, British Columbia, Canada

  2. 2

    University of Cape Town, Department of Psychiatry and Mental Health, Cape Town, South Africa

  3. 3

    Queen Elizabeth II Hospital, National Obsessive Compulsive Disorders Treatment Service, Welwyn Garden City, Hertfordshire, UK

  4. 4

    University of Cambridge, Department of Psychiatry, Cambridge, UK

*Dan J Stein, Department of Psychiatry and Mental Health, University of Cape Town, Education Centre, Valkenberg Hospital, Private Bage X1, Observatory, Cape Town, 7925, South Africa.

Publication History

  1. Publication Status: New
  2. Published Online: 8 NOV 2013


[Figure 1]
Figure 1. PRISMA flow diagram.
[Figure 2]
Figure 2. Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
[Figure 3]
Figure 3. Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
[Analysis 1.1]
Analysis 1.1. Comparison 1 Sertraline versus placebo, Outcome 1 Massachusetts Hair-pulling scale.